Skip to main content
SpringerLink
Log in
Book cover

Colorectal Cancer pp 209–231Cite as

Management of Locally Unresectable Rectal Cancer

  • Chapter

  • 240 Accesses

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

The use of postoperative combined-modality therapy (5-fluorouracil [5-FU]-based chemotherapy plus concurrent pelvic radiation therapy) significantly improves local control and survival for patients with clinically resectable, transmural (T3) rectal cancer (1–4). For patients with unresectable disease (T4), it is more difficult to obtain these results.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N. Engl. J. Med., 312 (1985) 1465–1472.

    Article  Google Scholar 

  2. Gastrointestinal Tumor Study Group. Adjuvant therapy of colon cancer: results of a prospectively randomized trial. N. Engl. J. Med., 310 (1984) 737–743.

    Article  Google Scholar 

  3. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, etal. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med., 324 (1991) 709–715.

    Article  PubMed  CAS  Google Scholar 

  4. Wolmark N, Weiand HS, Hyams DM, Colangelo L, Dimitrov N, Romond EH, etal. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project protocol R-02. J. Natl. Cancer Inst., 92 (2000) 388–396.

    Article  PubMed  CAS  Google Scholar 

  5. Guillem JG, Puig-La Calle J, Akhurst T, Tickoo S, Ruo L, Minsky BD, etal. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis. Colon Rectum, 43 (2000) 18–24.

    Article  PubMed  CAS  Google Scholar 

  6. Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, etal. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis. Colon Rectum, 53 (2000) 759–770.

    Article  Google Scholar 

  7. Dosoretz DE, Gunderson LL, Hedberg S, Hoskins B, Blitzer PH, Shipley W, etal. Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas. Cancer, 52 (1983) 814–818.

    Article  PubMed  CAS  Google Scholar 

  8. Medical Research Council Rectal Cancer Working Party. Randomized trial of surgery alone versus radiotherapy followed by surgery for potentially operable, locally advanced rectal cancer. Lancet, 348 (1996) 1605–1609.

    Article  Google Scholar 

  9. Willett CG, Shellito PC, Tepper JE, Eliseo R, Convery K, and Wood WC. Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma. J. Clin. Oncol., 9 (1991) 843–849.

    PubMed  CAS  Google Scholar 

  10. Willett CG, Shellito PC, Tepper JE, Eliseo R, Convery K, and Wood WC. Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma. Cancer, 67 (1991) 1504–1508.

    Article  PubMed  CAS  Google Scholar 

  11. Mendenhall WM, Bland KI, Pfaff WW, Million RR, and Copeland EM III. Initially unresectable rectal adenocarcinoma treated with preoperative irradiation and surgery. Ann. Surg., 205 (1986) 41–44.

    Article  Google Scholar 

  12. Marsh RW, Chu NM, Vauthey JN, Mendenhall WM, Lauwers GY, Bewsher C, etal. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy. Cancer, 78 (1996) 217–225.

    Article  PubMed  CAS  Google Scholar 

  13. Tobin RL, Mohiuddin M, and Marks G. Preoperative irradiation for cancer of the rectum with extrarectal fixation. Int. J. Radial. Oncol. Biol. Phys., 21 (1991) 1127–1132.

    Article  CAS  Google Scholar 

  14. Minsky BD, Cohen AM, Enker WE, Harrison LB, and Sigurdson E. Radiation therapy for unresectable rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 21 (1991) 1283–1289.

    Article  PubMed  CAS  Google Scholar 

  15. Mohiuddin M, Regine WF, John WJ, Hagihara PF, McGrath PC, Kenady DE, etal. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int. J. Radiat. Oncol. Biol. Phys., 46 (2000) 883–888.

    Article  PubMed  CAS  Google Scholar 

  16. Willett CG, Shellito PC, Rodkey GV, and Wood WC. Preoperative irradiation for tethered rectal carcinoma. Radiother. Oncol., 21 (1991) 141–142.

    Article  PubMed  CAS  Google Scholar 

  17. Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen D, Reichman B, etal. Enhancement of radiation induced downstaging of rectal cancer by 5-FU and high dose leucovorin chemotherapy. J. Clin. Oncol., 10 (1992) 79–84.

    PubMed  CAS  Google Scholar 

  18. Minsky BD, Cohen A, Enker W, Kelsen D, Kemeny N, Ilson D, etal. Pre-operative 5-FU, low dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer, 73 (1994) 273–278.

    Article  PubMed  CAS  Google Scholar 

  19. Minsky BD, Cohen AM, Enker WE, Harrison LB, Fass D, and Sigurdson E. Intraoperative brachytherapy alone in incompletely resected recurrent rectal cancer. Radiother. Oncol., 21 (1991) 115–120.

    Article  PubMed  CAS  Google Scholar 

  20. Dibiase SJ, Rosenstock JG, Shabason L, and Corn BW. Tumor bed brachytherapy with a mesh template: an accessible alternative to intraoperative radiotherapy. J. Surg. Oncol., 66 (1997) 104–109.

    Article  PubMed  CAS  Google Scholar 

  21. Minsky BD, Kemeny N, Cohen AM, Enker WE, Kelsen DP, Reichman B, etal. Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer, 67 (1991) 2859–2866.

    Article  PubMed  CAS  Google Scholar 

  22. Harrison LB, Minsky BD, Enker WE, Mychalczak B, Guillem J, Paty PB, etal. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Ins. J. Radias. Oncol. Biol. Phys., 42 (1998) 325–330.

    Article  CAS  Google Scholar 

  23. Huber FT, Stepan R, Zimmermann F, Fink U, Molls M, and Siewert JR. Locally advanced rectal cancer: resection and intraoperative radiotherapy using the flab method combined with preoperative or postoperative radiochemotherapy. Dis. Colon Rectum, 39 (1996) 774–779.

    Article  PubMed  CAS  Google Scholar 

  24. Lowy AM, Rich TA, Skibber JM, Dubrow RA, and Curley SA. Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma. Ann. Surg., 223 (1996) 177–185.

    Article  PubMed  CAS  Google Scholar 

  25. Wallace JH, Willett CG, Shellito PC, Coen JJ, and Hoover HC. Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. J. Surg. Oncol., 60 (1995) 122–127.

    Article  PubMed  Google Scholar 

  26. Nakfoor BM, Willett CG, Shellito PC, Kaufman DS, and Daly WJ. The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer. Ann. Surg., 228 (1998) 194–200.

    Article  PubMed  CAS  Google Scholar 

  27. Gunderson LL, Nelson H, Martenson JA, Cha S, Haddock M, Devine R, etal. Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation + 5-FU. Ins. J. Radiat. Oncol. Biol. Phys., 37 (1997) 601–614.

    Article  CAS  Google Scholar 

  28. Kallinowski F, Eble Mi, Buhr HJ, Wannenmacher M, an Herfarth CH. Intraoperative radiotherapy for primary and recurrent rectal cancers. Eur. J. Surg. Oncol., 21 (1995) 191–194.

    Article  PubMed  CAS  Google Scholar 

  29. Kim HK, Jessup JM, Beard CJ, Bornstein B, Cady B, Stone MD, etal. Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy. Int. J. Radiat. Oncol. Biol. Phys., 38 (1997) 777–783.

    Article  PubMed  CAS  Google Scholar 

  30. Gunderson LL, Nelson H, Martenson JA, Cha S, Haddock M, Devine R, etal. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer. Dis. Colon Rectum, 39 (1996) 1379–1395.

    Article  PubMed  CAS  Google Scholar 

  31. Valentini V, Morganti AG, De Franco A, Coco C, Ratto C, Doglietto GB, etal. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma. Prognostic factors and long term outcome. Cancer, 86 (1999) 2612–2624.

    Article  PubMed  CAS  Google Scholar 

  32. Grinnell RS. The lymphatic and venous spread of carcinoma of the rectum. Ann. Surg., 116 (1942) 200–215.

    Article  PubMed  CAS  Google Scholar 

  33. Bussieres E, Gilly FN, Rouanet P, Mahe MA, Roussel A, Delannes M, etal. Recurrences of rectal cancers: results of a multimodal approach with intraoperative radiation therapy. Int. J. Radiat. Oncol. Biol. Phys., 34 (1995) 49–56.

    Article  Google Scholar 

  34. Mannaerts GHH, Martijn H, Crommelin MA, Stultiens GNM, Dries W, Repelaraer van Driel OJ, etal. Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 45 (1999) 297–308.

    Article  PubMed  CAS  Google Scholar 

  35. Eble MJ, Lehnert T, Treiber M, Latz D, Herfarth C, and Wannenmacher M. Moderate dose intraoperative and external beam radiotherapy for locally recurrent rectal carcinoma. Radiother. Oncol., 49 (1998) 169–174.

    Article  PubMed  CAS  Google Scholar 

  36. Hashiguchi Y, Sekine T, Sakamoto H, Tanaka Y, Kazumoto T, Kato S, etal. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis. Colon Rectum, 42 (1999) 886–895.

    Article  PubMed  CAS  Google Scholar 

  37. LeCouteur RA, Gillette EL, Powers BE, Child G, McChesney SL, Ingram JT. Peripheral neuropathies following experimental intraoperative radiation therapy. Int. J. Radiat. Oncol. Biol. Phys., 17 (1989) 583–590.

    Article  PubMed  CAS  Google Scholar 

  38. Powers BE, Gillette EL, McChesney SL, LeCouteur RA, and Withrow SJ. Bone necrosis and tumor induction following experimental intraoperative irradiation. Int. J. Radiat. Oncol. Biol. Phys., 17 (1989) 559–567.

    Article  PubMed  CAS  Google Scholar 

  39. Vujaskovic Z, Gillette SM, Powers BE, Stukel TA, LaRue SM, Gillette EL, etal. Effects of intraoperative irradiation and intraoperative hyperthermia on canine sciatic nerve: neurologic and electrophysiologic study. Int. J. Radiat. Oncol. Biol. Phys., 34 (1995) 125–131.

    Article  Google Scholar 

  40. Vujaskovic Z, Powers BE, Paardekoper G, Gillette SM, Gillette EL, and Colaacchio TA. Effects of intraoperative irradiation (IORT) and intraoperative hyperthermia (IOHT) on canine sciatic nerve: histopathological and morphometric studies. Int. J. Radiat. Oncol. Biol. Phys., 43 (1999) 1103–1109.

    Article  PubMed  CAS  Google Scholar 

  41. Johnstone PAS, Laskin WB, DeLuca AM, Barnes M, Kinsella TJ, and Sindelar WF. Tumors in dogs exposed to experimental intraoperative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 34 (1996) 853–857.

    Article  PubMed  CAS  Google Scholar 

  42. Gunderson LL, O’Connell MJ, and Dozois RR. The role of intraoperative irradiation in locally advanced primary and recurrent rectal adenocarcinoma. World J. Surg., 16 (1992) 495–501.

    Article  PubMed  CAS  Google Scholar 

  43. Lanciano RM, Calkins AR, Wolkov HB, Buzydlowski J, Noyes RD, Sause W, etal. A phase I/II study of intraoperative radiotherapy in advanced unresectable or recurrent carcinoma of the rectum: a radiation therapy oncology group (RTOG) study. J. Surg. Oncol., 53 (1993) 20–29.

    Article  PubMed  CAS  Google Scholar 

  44. Noyes RD, Weiss SM, Krall JM, Sause WT, Owens JR, Wolkov HB, etal. Surgical complications of intraoperative radiation therapy: the Radiation Therapy Oncology Group experience. J. Surg. Oncol., 50 (1993) 209–215.

    Article  Google Scholar 

  45. Minsky BD, Conti J, Cohen AM, Kelsen DP, Saltz L, Guillem J, etal. Acute toxicity of neoadjuvant bolus 5-FU/methotrexate and leucovorin rescue followed by continuous infusion 5-FU plus pre-operative radiation therapy for rectal cancer. Radiat. Oncol. Invest., 4 (1996) 90–97.

    Article  CAS  Google Scholar 

  46. Perera F, Fisher B, Kocha W, Plewes E, Taylor M, and Vincent M. A phase I pilot study of pelvic radiation and alpha-2A interferon in patients with locally advanced or recurrent rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 37 (1997) 297–303.

    Article  PubMed  CAS  Google Scholar 

  47. Botwood N, James R, Vernon C, and Price P. A phase I study of “Tomudex” (raltitrexed) with radiotherapy (RT) as adjuvant treatment in patients (pt) with operable rectal cancer. Proc. ASCO, 17 (1998) 277a (abstract).

    Google Scholar 

  48. James RD, Price P, and Valentini V. Raltitrexed (Tomudex) concomitant with radiotherapy as adjuvant treatment for patients with rectal cancer: preliminary results of phase I studies. Eur. J. Cancer, 35 (1999) s19 - s22.

    Article  PubMed  CAS  Google Scholar 

  49. Valentini V, Morganti AG, Fiorentino G, Luzi S, Smaniotto D, Turriziani A, etal. Chemoradiation with raltitrexed (Tomudex) and concomitant preoperative radiotherapy has potential in the treatment of stage I11111 resectable rectal cancer. Proc ASCO, 18 (1999) 257a (abstract).

    Google Scholar 

  50. James RD, Price P and Smith M. Raltitrexed (Tomudex) plus radiotherapy is well tolerated and warrants further investigation in patients with advanced inoperable/recurrent rectal cancer. Proc. ASCO, 18 (1999) 288a (abstract).

    Google Scholar 

  51. Feliu J, Calvillo J, Escribano A, De Castro J, Espinosa A, Ordonez A, etal. Neoadjuvant therapy of rectal carcinoma with UFT-folinic acid (LV) plus radiotherapy. Proc. ASCO, 18 (1999) 239a (abstract).

    Google Scholar 

  52. Pfeiffer P. Concurrent UFT/L-leucovorin and curative intended radiotherapy (60 Gy) in patients with locally advanced rectal cancer (LARC): a phase I/II trial. Proc. ASCO, 19 (2000) 255a (abstract).

    Google Scholar 

  53. Mitchell E, Ahmad N, Fry RD, Anne PR, Rakanic J, Goldstein SD, etal. Combined modality therapy of locally advanced or recurrent adenocarcinoma of the rectum: preliminary report of a phase I trial of chemotherapy (CT) with CPT-11,5-FU, and concomitant irradiation (RT). Proc. ASCO, 18 (1999) 247a (abstract).

    Google Scholar 

  54. Minsky BD, O’Reilly E, Wong D, Sharma S, Paty P, Guillem J, etal. Daily low-dose irinotecan (CPT-11) plus pelvic irradiation as preoperative treatment of locally advanced rectal cancer. Proc. ASCO, 18 (1999) 266a (abstract).

    Google Scholar 

  55. Anne P, Mitchell EP, Ahmad N, Fry RD, Rakinic J, Goldstein SD, etal. Radiosensitization in locally advanced adenocarcinoma of the rectum using combined modality therapy (CMT) with CPT-11, 5-fluorouracil, concomitant irradiation. Proc ASCO, 19 (2000) 250 (abstract).

    Google Scholar 

  56. Carraro S, Roca E, Cartelli C, Rafailovici L, Lougedo M, Wasserman E, etal. Oxaliplatin (OXA), 5-florouracil (5-FU) and leucovorin (LV) plus radiotherapy in unresectable rectal cancer (URC): preliminary results. Proc. ASCO, 19 (2000) 291a (abstract).

    Google Scholar 

  57. Freyer G, Bossard N, Romestaing P, Mornex F, Trillet-Lenoir V, and Gerard JP. Oxaliplatin (OXA), 5-fluorouracil (5-FU), L-folinic acid (FA) and concomitant irradiation in patients with rectal cancer; a phase I study. Proc. ASCO,19 (2000) 260a (abstract).

    Google Scholar 

  58. Glynne-Jones R, Falk S, Maughan T, Sebag-Montefiore D, Meadows HM, and Das-Gupta A. Results of preoperative radiation and oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV). Proc. ASCO, 19 (2000) 310a (abstract).

    Google Scholar 

  59. Cohen DP, Lee CG, Anscher MS, Ludwig KA, Tyler DS, Seigler HF, etal. Phase I study of chemoradiation therapy with oral Eniluracil (776C85)/5-fluorouracil in patients with rectal adenocarcinoma. Proc. ASCO, 19 (2000) 261a (abstract).

    Google Scholar 

  60. Dunst J, Reese T, and Frings S. Phase I study of Capecitabine combined with standard radiotherapy in patients with rectal cancer. Proc. ASCO, 19 (2000) 256a (abstract).

    Google Scholar 

  61. Minsky BD, Cohen A, Enker W, Kelsen D, Kemeny N, Ilson D, etal. Pre-operative 5-FU, low dose leucovorin, and radiation therapy for locally advanced/unresectable rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 37 (1997) 289–295.

    Article  PubMed  CAS  Google Scholar 

  62. Shibata D, Guillem JG, Lanouette NM, Paty P, Minsky B, Harrison L, etal. Functional and quality of life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation. Dis. Colon Rectum, 43 (2000) 752–758.

    Article  PubMed  CAS  Google Scholar 

  63. Kaminsky-Forrett MC, Conroy T, Luporsi E, Peiffert D, Lapeyre M, Boissel P, etal. Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 42 (1998) 935–941.

    Article  PubMed  CAS  Google Scholar 

  64. Ahmad NR, Nagle DA, and Topham A. Pathologic complete response predicts long-term survival following preoperative radiation therapy for rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 39 (1997) 284 (abstract).

    Article  Google Scholar 

  65. Gama AH, Gansl RC, Souza PMB, Simon SD, Costa FO, Aguilar PB, etal. Primary treatment of low rectal cancer with combined chemotherapy and radiation therapy (C+RT): results of a pilot study. Proc. ASCO, 12 (1993) 215 (abstract).

    Google Scholar 

  66. Willett CG, Hagan M, Daley W, Warland G, Shellito PC, and Compton CC. Changes in tumor proliferation of rectal cancer induced by preoperative 5-fluorouracil and irradiation. Dis. Colon Rectum, 41 (1998) 62–67.

    Article  PubMed  CAS  Google Scholar 

  67. Fu CG, Tominaga 0, Nagawa H, Nita ME, Masaki T, Ishimaru G, etal. Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis. Colon Rectum, 41 (1988) 58–74.

    Google Scholar 

  68. Sakakura C, Koide KI, Kimura A, Taniguchi H, Hagiwara A, Yamaguchi T, etal. Analysis of histologic therapeutic effect, apoptosis rate and p53 status after combined treatment with radiation, hyperthermia, and 5-fluorouracil suppositories for advanced rectal cancers. Br. J. Cancer, 77 (1998) 159–166.

    Article  PubMed  CAS  Google Scholar 

  69. Scott N, Hale A, Deakin M, Hand P, Adab FA, Hall C, etal. A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53, and bc1–2 expression. Eur. J. Surg. Oncol., 24 (1998) 169–173.

    Article  PubMed  CAS  Google Scholar 

  70. Tannapfel A, Nusslein S, Fietkau R, Katalinic A, Kockerling F, and Wittekind C. Apoptosis, proliferation, bax, bc1–2, and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 41 (1998) 585–591.

    Article  PubMed  CAS  Google Scholar 

  71. Luna-Perez P, Arriola EL, Cuadra Y, Alvarado I, and Quintero A. p53 Protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma. Ann. Surg. Oncol., 5 (1998) 203–208.

    Article  PubMed  CAS  Google Scholar 

  72. Nehls 0 Klump B, Holzmann K, Lammering G, Borchard F, Gruenagel HH, etal. Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma. Cancer,85 (1999) 2541–2548.

    Google Scholar 

  73. Adell G, Sun XF, 011e S, Klintenberg C, Sjodahl R, and Nordenskjold B. p53 Status: an indicator for the effect of preoperative radiotherapy of rectal cancer. Radiother. Oncol., 51 (1999) 169–174.

    Article  PubMed  CAS  Google Scholar 

  74. Willett CG, Warland G, Coen J, Shellito PC, and Compton CC. Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation. Int. J. Radiat. Oncol. Biol. Phys., 32 (1995) 57–61.

    Article  PubMed  CAS  Google Scholar 

  75. Willett CG, Warland G, Hagan MP, Daly WJ, Coen J, Shellito PC, etal. Tumor proliferation in rectal cancer following preoperative irradiation. J. Clin. Oncol., 13 (1995) 1417–1424.

    PubMed  CAS  Google Scholar 

  76. Rich TA. Infusional chemoradiation for operable rectal cancer: post-, pre-, or nonoperative management? Oncology, 11 (1997) 295–315.

    Google Scholar 

  77. Rich TA, Sinicrope F, Stephens C, Myen R, Terry N, Meistrich M, etal. Downstaging of T3 rectal cancer after preoperative infusional chemoradiation is correlated with spontaneous apoptosis index and BCL-2 staining. Int. J. Radiat. Oncol. Biol. Phys., 36 (1996) 259 (abstract).

    Article  Google Scholar 

  78. Berger C, de Muret A, Garaud P, Chapet S, Bourlier P, Reynaud-Bougnoux A, etal. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor density (RTCD): prognostic implications. Int. J. Radiat. Oncol. Biol. Phys., 37 (1997) 619–627.

    Article  PubMed  CAS  Google Scholar 

  79. Desai GR, Meyerson RJ, Higashikubo R, Birnbaum E, Fleshman J, Fry R, etal. Carcinoma of the rectum: possible cellular predictors of metastatic potential and response to radiation therapy. Dis. Colon Rectum, 39 (1996) 1090–1096.

    Article  PubMed  CAS  Google Scholar 

  80. Neoptolemos JP, Oates GD, Newbold KM, Robson AM, McConkey C, and Powell J. Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes’ or Jass’ classifications for colorectal cancer. Br. J. Surg., 82 (1995) 184–187.

    Article  PubMed  CAS  Google Scholar 

  81. Nicholl ID and Dunlop MG. Molecular markers of prognosis in colorectal cancer. J. Natl. Cancer Inst., 91 (1999) 1267–1269.

    Article  PubMed  CAS  Google Scholar 

  82. Goes RN, Beart RW, Simons AJ, Gunderson LL, Grado G, and Streeter O. Use of brachytherapy in management of locally recurrent rectal cancer. Dis. Colon Rectum, 40 (1997) 1177–1179.

    Article  PubMed  CAS  Google Scholar 

  83. Magrini S, Nelson H, Gunderson L, and Sim FH. Sacropelvic resection and intraoperative electron irradiation in the management of recurrent anorectal cancer. Dis. Colon Rectum, 39 (1996) 1–9.

    Article  PubMed  CAS  Google Scholar 

  84. Lingareddy V, Ahmad NR, and Mohiuddin M. Palliative reirradiation for recurrent rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 38 (1997) 785–790.

    Article  PubMed  CAS  Google Scholar 

  85. Nag S, Martinez-Monge R, Mills J, Bauer C, Grecula J, Nieroda C, etal. Intraoperative high dose rate brachytherapy in recurrent metastatic colorectal carcinoma. Ann. Surg. Oncol., 5 (1998) 16–22.

    Article  PubMed  CAS  Google Scholar 

  86. Schild SE, Martenson JA, Gunderson LL, and Dozois RR. Long-term survival and patterns of failure after postoperative radiation therapy for subtotally resected rectal adenocarcinoma. Int. J Radiat. Oncol. Biol. Phys., 16 (1989) 459–463.

    Article  PubMed  CAS  Google Scholar 

  87. Suzuki K, Gunderson LL, Devine RM, Weaver AM, Dozois RR, Ilstrup DM, etal. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer, 75 (1995) 939–952.

    Article  PubMed  CAS  Google Scholar 

  88. Allee PE, Tepper JE, Gunderson LL, and Munzenrider JE. Postoperative radiation therapy for incompletely resected colorectal carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 17 (1989) 1171–1176.

    Article  PubMed  CAS  Google Scholar 

  89. Papillon J and Berard PH. Endocavitary irradiation in the conservative treatment of adenocarcinoma of the low rectum. World J. Surg., 16 (1992) 451–457.

    Article  PubMed  CAS  Google Scholar 

  90. Kodner IJ and Shemesh EI. Radiation therapy as definitive treatment for adenocarcinoma of the rectum. Surgery, 114 (1993) 850–860.

    PubMed  CAS  Google Scholar 

  91. Brierley JD, Cummings BJ, Wong CS, Keane TJ, O’Sullivan B, Catton CN, etal. Adenocarcinoma of the rectum treated by radical external radiation therapy. Int. J. Radiat. Oncol. Biol. Phys., 31 (1995) 255–259.

    Article  PubMed  CAS  Google Scholar 

  92. Wong CS, Cummings BJ, Brierley JD, Catton CN, McLean M, Catton P, etal. Treatment of locally recurrent rectal carcinoma-results and prognostic factors. Int. J. Radiat. Oncol. Biol. Phys., 40 (1998) 427–435.

    Article  PubMed  CAS  Google Scholar 

  93. Guiney MJ, Smith JG, Worotniuk V, Ngan S, and Blakey D. Radiotherapy treatment for isolated loco-regional recurrence of rectosigmoid cancer following definitive surgery: Peter McCallum Cancer Institute experience: 1981–1990. Int. J. Radiat. Oncol. Biol. Phys., 38 (1997) 1019–1025.

    Article  PubMed  CAS  Google Scholar 

  94. Gerard JP, Roy P, Coquard R, Barbet N, Romestaing P, Ayzac L, etal. Combined curative radiation therapy alone in (Ti) T2–3 rectal adenocarcinoma: a pilot study of 29 patients. Radiother. Oncol., 38 (1996) 131–137.

    Article  PubMed  CAS  Google Scholar 

  95. Overgaard M, Overgaard J, and Sell A. Dose-response relationship for radiation therapy of recurrent, residual, and primarily inoperable colorectal cancer. Radiother. Oncol., 1 (1984) 217–225.

    Article  PubMed  CAS  Google Scholar 

  96. Valentini V, Morganti AG, Luzi S, Mantello G, Mantini G, Salvi G, etal. Is chemoradiation feasible in elderly patients? A study of 17 patients with anorectal carcinoma. Cancer, 80 (1997) 1387–1392.

    Article  PubMed  CAS  Google Scholar 

  97. Rominger CJ, Gelber RD, Gunderson LL, and Conner N. Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery. Radiation Therapy Oncology Group study (76–16). Am. J. Clin. Oncol., 8 (1985) 118–127.

    Article  PubMed  CAS  Google Scholar 

  98. Danjoux CE, Gelber RD, Catton GE, and Klaassen DJ. Combination chemo-radiotherapy for residual, recurrent, or inoperable carcinoma of the rectum: ECOG Study (EST 3276). Int. J. Radiat. Oncol. Biol. Phys., 11 (1985) 765–771.

    Article  PubMed  CAS  Google Scholar 

  99. Nishimura Y, Hiraoka M, Akuta K, Jo S, Nagata Y, Masunaga SI, etal. Hyperthermia combined with radiation therapy for primarily unresectable and recurrent colorectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 23 (1992) 759–768.

    Article  PubMed  CAS  Google Scholar 

  100. Graf R, Wust P, Gellermann J, Mohr B, Gogler H, Riess H, etal. Phase II trial of radiation therapy with 45 Gy, 5-fluorouracil (5-FU), and mitomycin-C (MMC) in patients with anal cancer-a rationale to add regional hyperthermia. Int. J. Radiat. Oncol. Biol. Phys., 36 (1996) 296 (abstract).

    Article  Google Scholar 

  101. Furuta K, Konishi F, Kanazawa K, Saito K, and Sugawara T. Synergistic effects of hyperthermia in preoperative radiochemotherapy for rectal carcinoma. Dis. Colon Rectum, 40 (1997) 1303–1312.

    Article  PubMed  CAS  Google Scholar 

  102. Ohno S, Tomoda M, Tomisaki S, Kitamura K, Mori M, Maehara Y, etal. Improved surgical results after combining preoperative hyperthermia with chemotherapy and radiotherapy for patients with carcinoma of the rectum. Dis. Colon Rectum, 40 (1997) 401–406.

    Article  PubMed  CAS  Google Scholar 

  103. Ichikawa D, Yamaguchi T, Yoshioka Y, Sawai K, and Takahashi T. Prognostic evaluation of preoperative combined treatment for advanced cancer in the lower rectum with radiation, intraluminal hyperthermia, and 5-fluorouracil suppository. Am. J. Surg., 171 (1996) 346–350.

    Article  PubMed  CAS  Google Scholar 

  104. Anscher MS, Lee C, Hurwitz HI, Tyler DS, Prosnitz LR, Jowell P, etal. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 47 (2000) 719–724.

    Article  PubMed  CAS  Google Scholar 

  105. Emami B Myerson RJ, Scott C, Gibbs F, Lee C, and Perez CA. Phase I/II study, combination of radiotherapy and hyperthermia in patients with deep-seated malignant tumors: report of a pilot study by the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys.,20 (1991) 73–79.

    Google Scholar 

  106. Duncan W, Arnott SJ, Jack WJL, On JA, Ken GR, and Williams JR. Results of two randomized trials of neutron therapy in rectal adenocarcinoma. Radiother. Oncol., 8 (1987) 191–198.

    Article  PubMed  CAS  Google Scholar 

  107. Battermann JJ. Results of d+T fast neutron irradiation on advanced tumors of the bladder and rectum. Int. J. Radiat. Oncol. Biol. Phys., 8 (1982) 2159–2164.

    Article  PubMed  CAS  Google Scholar 

  108. Pu AT, Robertson JM, and Lawrence TS. Current status of radiation sensitization by fluoropyrimidines. Oncology, 9 (1995) 707–714.

    PubMed  CAS  Google Scholar 

  109. Rhomberg W, Eiter H, Hergan K, and Schneider B. Inoperable recurrent rectal cancer: results of a prospective trial with radiation therapy and razoxane. Int. J. Radiat. Oncol. Biol. Phys., 30 (1994) 419–425.

    Article  PubMed  CAS  Google Scholar 

  110. Talley NA, Chen F, King D, Jones M, and Talley NJ. Short-chain fatty acids in the treatment of radiation proctitis. A randomized, double-blind, placebo-controlled, cross-over pilot trial. Dis. Colon Rectum, 40 (1997) 1046–1050.

    Article  PubMed  CAS  Google Scholar 

  111. O’Brien PC, Franklin CI, Dear KBG, Hamilton CC, Poulsen M, Joseph DJ, etal. A phase III double-blind randomised study of rectal sufralfate suspension in the prevention of acute radiation proctitis. Radiother. Oncol., 45 (1997) 117–123.

    Article  PubMed  Google Scholar 

  112. Martenson JA Jr, Bollinger JW, Sloan JA, Novotny PJ, Utias RE, Michalak JC, etal. Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: a North Central Cancer Treatment Group Phase III double-blind placebo-controlled trial. J. Clin. Oncol., 18 (2000) 1239–1245.

    PubMed  CAS  Google Scholar 

  113. Martenson JA, Hyland G, Moertel CG, Mailliard JA, O’Fallon JR, Collins RT, etal. Olsalizine is contraindicated during pelvic radiation therapy: results of a double-blind randomized clinical trial. Int. J. Radiat. Oncol. Biol. Phys., 35 (1996) 299–303.

    Article  PubMed  CAS  Google Scholar 

  114. Resbeut M, Marteau P, Cowen D, Richaud P, Bourdin S, Dubois JB, etal. A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. Radiother. Oncol., 44 (1997) 59–63.

    Article  PubMed  CAS  Google Scholar 

  115. Baughan CA, Canney PA, Buchanan RB, and Pickering RM. A randomized trial to assess the efficacy of 5-aminosalicylic acid for the prevention of radiation enteritis. Clin. Oncol., 5 (1993) 19–24.

    Article  CAS  Google Scholar 

  116. Liu T, Liu Y, He S, Zhang Z, and Kligerman MM. Use of radiation with or without WR-2721 in advanced rectal cancer. Cancer, 69 (1992) 2820–2825.

    Article  PubMed  CAS  Google Scholar 

  117. Montana GS, Anscher MS, Mansbach CM II, Daly N, Delannes M, Clarke-Pearson D, etal. Topical application of WR-2721 to prevent radiation-induced proctosigmoiditis. Cancer, 69 (1992) 2826–2830.

    Article  PubMed  CAS  Google Scholar 

  118. Withers HR. Biological basis for altered fractionation schemes. Cancer, 55 (1985) 2086–2095.

    Article  PubMed  CAS  Google Scholar 

  119. Coucke PA, Cuttat JF, and Mirimanoff RO. Adjuvant postoperative accelerated hyperfractionated radiotherapy in rectal cancer: a feasibility study. Int. J. Radiat. Oncol. Biol. Phys., 27 (1993) 885–889.

    Article  PubMed  CAS  Google Scholar 

  120. Coucke PA, Sartorelli B, Cuttat JF, Jeanneret W, Gillet M, and Mirimanoff RO. The rationale to switch from postoperative hyperfractionated accelerated radiotherapy to preoperative hyperfractionated accelerated radiotherapy in rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 32 (1995) 181–188.

    Article  PubMed  CAS  Google Scholar 

  121. Bozzetti F, Baratti D, Andreola S, Zucali R, Schiavo M, Spinelli P, etal. Preoperative radiation therapy for patients with T2–T3 carcinoma of the middle-to-lower rectum. Cancer, 86 (1999) 398–404.

    Article  PubMed  CAS  Google Scholar 

  122. Movsas B, Hanlon A, Lanciano R, Scher RM, Weiner LM, Sigurdson ER, etal. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 42 (1998) 43–50.

    Article  PubMed  CAS  Google Scholar 

  123. Tait DM, Nahum AE, Meyer LC, Law M, Dearnaley DP, Horwich A, etal. Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother. Oncol., 42 (1997) 121–136.

    Article  PubMed  CAS  Google Scholar 

  124. Shank B, LoSasso T, Brewster L, Burman C, Cheng E, Chu JCH, etal. Three-dimensional treatment planning for post-operative treatment of rectal carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 21 (1991) 253–265.

    Article  PubMed  CAS  Google Scholar 

  125. Isacsson U, Montelius A, Jung B, and Glimelius B. Comparative treatment planning between proton and X-ray therapy in locally advanced rectal cancer. Radiother. Oncol., 41 (1997) 263–272.

    Article  Google Scholar 

Download references

Authors
  1. Bruce D. Minsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Gastrointestinal Oncology Division, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Leonard B. Saltz MD

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Minsky, B.D. (2002). Management of Locally Unresectable Rectal Cancer. In: Saltz, L.B. (eds) Colorectal Cancer. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-160-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-160-2_12

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9670-3

  • Online ISBN: 978-1-59259-160-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation